Map of DNA Give new hope to cancer treatment

Map of DNA Give new hope to cancer treatment

Cancer can be a disease that can be controlled so that it is no longer a killer disease. The findings obtained from the research of several experts in the United Kingdom carried out over five years.

All patients will soon have DNA of the tumor and genetisnya code so that the doctor can ensure they can provide the right medicine.

Doctors hope to do more research so as to change certain types of cancer to be a disease that no longer pose fatal consequences.

According to specialist doctors at the Institute of Cancer Research in London, these techniques can stop disease patients who now estimate that only lasted for a few months to be healthy for a decade or more.

"We aspire to cure cancer. However, for people in chronic conditions, it will be a question of how to make them better conditions so that they can live longer for several years, "said Chief Executive Officer at the Institute of Cancer Research, Professor Alan Ashworth.

"Cancer often appear among people who are old and we can make them live longer," he added.

Professor Ashworth says that to understand how different cancer caused by different genetic factors built extraordinarily fast.

Tumor genetic profiling has been used most, but that method is now only seen on a few genes. breast cancer affected Women are tested to see how tumornya have certain variants in the gene HER2, which becomes the cause of the fifth. Patients who were given Herceptin, but wear the same remedy will not get better without the Gene Variant.

Patients with cancer melanoma with a particular gene mutation were given pills Vemurafenib to be able to survive 6 to 13.2 months and help patients more energetic.

However, the median survival of patients varies. A patient at the Royal Marsden in Chelsea, where the College was founded, has survived ten years after kankernya disease treated with Herceptin therapy.

Professor Ashworth says there are exceptions for some cases. He added, "We hope patients can return to normal. By activating the patient profile and merentetkan berespons their genome, we can find the genes that are responsible for it.

The College wants to help data centers (database) and identifying the DNA of many genes responsible for cancer. It has launched about three years by the Tumor Profiles Unit projects worth £ 3 million. The project aimed at researching more about the genetic profile of a cancer.

Professor Ashworth stated, "this is not science fiction. When someone thought this would be a routine practice for every cancer patient for five or ten years. "

He thought it would have a major impact method against a series of cancer for a decade. Then, "in two or three years later would be individual patients receive substantial benefits from technologies."

He also thinks a genetic profile would make drug development recently became quicker and cheaper. But sometimes tumors can develop drug resistance in a few months.

Scientists hope to be able to deal with it in a way to monitor the tumor DNA requires re-biopsy. Experts at the Institute of Cancer Research is developing a blood test to test the DNA of the tumor-free.

Meanwhile, Chief Medical Officer at Macmillan Cancer Support, Professor Jane Maher, mentioning the new concept that it's interesting. However, the technology becomes a real challenge to find out how quickly this will happen. He also said that the tumor is a genetic mosaic and has excellent resistance to development of bai